ABSTRACT
The use of the immunomodulator OmniGen- AF® (OMN) feed supplement, where the response in milk yield, health, and reproduction is uncertain, allows for an application of type I (use the product when it is not profitable) and type II (do not use the product when it is profitable) analysis to aid decision making regarding its profitability. This study applies a type I and II error analysis to quantify the economic risk of investing in OMN feed supplementation using data from a controlled study and a field data set collected on dairy farms. Four prediction models were applied considering the expected value and standard deviation of the response in milk yield; milk and health; milk and reproduction; milk, health, and reproduction. Uncertainty in the milk response was modeled following a normal distribution with mean 0.15 kg/cow/d and standard deviation 0.81 kg/cow/d. This distribution was left-truncated at 0 kg, which resulted in a mean (expected) response of 0.7 kg/cow/d. Based on the field data set, the reduction in health costs and reproduction were estimated at $0.086 and $0.33/cow/day. All 3 responses were assumed to be present or not in the first 90 DIM. The increase in milk yields necessary to pay for the OMN supplementation considering a response in milk yield only, milk and health, milk and reproduction, and milk, health, and reproduction were 0.45, 0.19, -0.56, and -0.82 kg/cow/d respectively. The break-even OMN cost per cow per day when considering the increases in milk yield, milk and health, and milk and reproduction, milk, health, and reproduction were $0.23, $0.31, $0.56, and $0.65 respectively. Production responses resulted in costs exceeding revenue with a type I error cost of $2.62 for milk and $0.47 for milk and health response for the broke even. There was no type I error cost associated when considering the responses in milk and reproduction, and the combination of milk, health and reproduction which implies that there is no risk of using OMN when it is not profitable ( = the product is profitable for certain). Type II costs were associated with returns that are unrealized because of failing to use OMN when it is profitable with an opportunity cost of $9.92, $15.53, $37.23, and $45.08 per cow per day for the responses in milk yield; milk and health; milk and reproduction; and milk, health, and reproduction respectively. We concluded that a type I and II error analysis applied to the use of the OMN feed additive provided additional insights beyond a break-even analysis to support economic decision-making when the response on dairy farms is uncertain. The type I and II error analysis can aid in decision-making process to evaluate the adoption of a new technology.
ABSTRACT
Visual feedback normally helps guide movements to their goal. When moving one's hand, such guidance has to deal with a sensorimotor delay of about 100 ms. When moving a cursor, it also has to deal with a delay of tens of milliseconds that arises between the hand moving the mouse and the cursor moving on the screen. Moreover, the cursor is presented at a certain rate, so only positions corresponding with the position of the mouse at certain moments are presented. How does the additional delay and the rate at which cursor positions are updated influence how well the cursor can be guided to the goal? We asked participants to move a cursor to consecutive targets as quickly as they could. They did so for various additional delays and presentation rates. It took longer for the mouse to reach the target when the additional delay was longer. It also took longer when a lower presentation rate was achieved by not presenting the cursor all the time. The fraction of the time during which the cursor was present was more important than the rate at which the cursor's position was updated. We conclude that the way human arm movements are guided benefits from continuous access to recent visual feedback.
Subject(s)
Arm , Feedback, Sensory , Humans , Animals , Mice , Goals , Movement , Reaction Time , Psychomotor Performance , Visual PerceptionABSTRACT
Exoskeleton use in day-to-day plastering may face several challenges. Not all plasterer's tasks comprise of movements that will be supported by the exoskeleton and might even be hindered. Furthermore, use in practice might be jeopardised by time pressure, colleagues being negative, discomfort, or any other hindrance of the exoskeleton. We set up a field study, in which 39 plasterers were equipped with an exoskeleton for six weeks, to study exoskeleton usage. Moreover, we studied workload and fatigue, behaviour, productivity and quality, advantages and disadvantages, and acceptance. Exoskeleton use was dependent on the task performed but did not change over the course of the six weeks. For three tasks, higher exoskeleton use was associated with lower perceived loads, although differences were small. Advantages outweighed disadvantages for the majority of our population. This study shows that a majority of plasterers will wear the exoskeleton and is enthusiastic about the load reducing effect. Practitioner summary: For exoskeletons to make an impact on the health and well-being of workers, they need to be applicable in real work situations and accepted by the users. This study shows that 65% of the plasterers in this study want to use the exoskeleton in the future, for specific tasks.
Subject(s)
Exoskeleton Device , Humans , Arm , Movement , Workload , Fatigue , Biomechanical Phenomena , ElectromyographyABSTRACT
The objective of this study was to assess the efficacy and user's impression of an arm-support exoskeleton in complex and realistic ceiling construction tasks. 11 construction workers performed 9 tasks. We determined objective and subjective efficacy of the exoskeleton by measuring shoulder muscle activity and perceived exertion. User's impression was assessed by questionnaires on expected support, perceived support, perceived hindrance and future intention to use the exoskeleton. Wearing the exoskeleton yielded persistent reductions in shoulder muscle activity of up to 58% and decreased perceived exertion. Participants reported limited perceived hindrance by the exoskeleton, as also indicated by no increase in antagonistic muscle activity. The findings demonstrate the high potential of an arm-support exoskeleton for unloading the shoulder muscles when used in the dynamic and versatile working environment of a ceiling construction worker, which is in line with the consistent intention of the workers to use the exoskeleton in the future.Practitioner Summary: The majority of research focuses on the effect of using an arm-support exoskeleton during isolated postures and prescribed movements. We investigated the efficacy of an exoskeleton during a complex and realistic work, namely ceiling construction. Shoulder muscle activity was lower in almost all tasks when wearing the exoskeleton.
ABSTRACT
BACKGROUND: Clinical guidelines on cytomegalovirus (CMV) colitis in inflammatory bowel disease (IBD) are hampered by the low quality of evidence. In this study, we aim to explore the attitude and management of CMV colitis in IBD among gastroenterologists. METHODS: A web-based survey was distributed to adult and pediatric gastroenterologists and trainees in academic and general hospitals in the Netherlands. The survey comprised data collection on respondents' demographics, attitudes towards the importance of CMV infection in IBD on a visual analogue scale (from 0 to 100), and diagnostic and therapeutic strategies. RESULTS: A total of 73/131 invited respondents from 32 hospitals completed the survey (response rate of 56%). The importance of CMV infection was scored at a median 74/100. Respondents indicated CMV testing as appropriate in the clinical setting of steroid-refractory colitis (69% of respondents), hospitalized patients with active colitis (64%), immunomodulator or biological refractory colitis (55%) and active colitis irrespective of medication use (14%). CMV diagnostics include histology of colonic biopsies (88% of respondents), tissue CMV PCR (43%), serum CMV PCR (60%), CMV serology (25%) and fecal CMV PCR (4%). 82% of respondents start antiviral therapy after a positive CMV test on colonic biopsies (histology or PCR). CONCLUSIONS: Most Dutch gastroenterologists acknowledge the importance of CMV colitis in IBD. Strategies vary greatly with regard to the indication for testing and diagnostic method, as well as indication for the start of antiviral therapy. These findings underline the need for pragmatic clinical studies on different management strategies, in order to reduce practice variation and improve the quality of care. Summary of the established knowledge on this subject:The clinical significance of CMV-associated colitis in IBD remains a matter of debateRecommendations regarding CMV colitis in current international guidelines are based on low to moderate evidence levels and different diagnostic strategies are proposed What are the significant and/or new findings of this study?We show that there is a high practice variation of diagnosis and management of CMV colitis in IBD amongst adult and pediatric gastroenterologistsThis study underlined the need for pragmatic studies and guidelines on different management strategies including cut-off values to start therapy.
Subject(s)
Colitis, Ulcerative , Colitis , Cytomegalovirus Infections , Enterocolitis , Gastroenterologists , Inflammatory Bowel Diseases , Adult , Humans , Child , Cytomegalovirus Infections/complications , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/drug therapy , Inflammatory Bowel Diseases/complications , Inflammatory Bowel Diseases/diagnosis , Inflammatory Bowel Diseases/therapy , Colitis/therapy , Colitis/drug therapy , Antiviral Agents/therapeutic use , Colitis, Ulcerative/drug therapyABSTRACT
BACKGROUND: Studies about support needs of young adult childhood cancer survivors (YACCS) previously focused mainly on information needs. This study assessed support needs and associated factors (sociodemographic, medical, and psychosocial functioning) in Dutch YACCS. METHODS: YACCS (aged 18-30, diagnosed ≤ 18 years, time since diagnosis ≥ 5 years) cross-sectionally filled out a questionnaire regarding their need for various types of support (concrete information, personal counseling, and peer contact) in eight domains (physical consequences of childhood cancer, social-emotional consequences, relationships and sexuality, fertility, lifestyle, school and work, future perspective, insurance and mortgage), and questionnaires assessing health-related quality of life (PedsQL-YA), anxiety and depression (HADS), and fatigue (CIS-20R). Descriptive statistics were used to describe support needs. Linear regression was used to identify characteristics associated with support needs. RESULTS: One hundred fifty-one YACCS participated (response = 40%). Most YACCS reported a need for support in one or more domains (88.0%, N = 133). More than half of the participants reported a need for concrete information in the domains lifestyle, fertility, and physical consequences of childhood cancer and 25-50% in the domains insurance and mortgages, future perspective, and social-emotional consequences of childhood cancer. In the domains lifestyle and physical as well as emotional consequences of childhood cancer, 25-50% reported a need for counseling. Overall need for support was positively associated with middle (ß = 0.26, p = 0.024) and high (ß = 0.35, p = 0.014) compared to low educational attainment and (sub)clinical anxiety (ß = 0.22, p = 0.017), and negatively associated with social functioning (ß = - 0.37, p = 0.002) in multivariate analyses. CONCLUSION: YACCS report the strongest need for support, for concrete information, in the domains lifestyle, fertility, and physical consequences of childhood cancer. Associated factors were mostly socioeconomic and psychosocial in nature. Psychosocial care should be an integral part of survivorship care for YACCS, with screening for psychosocial problems, information provision including associated emotional consequences and support if necessary (psycho-education) and tailored interventions, and adequate referrals to more specialized care if necessary.
Subject(s)
Cancer Survivors , Neoplasms , Adolescent , Adult , Child , Health Services Needs and Demand , Humans , Neoplasms/psychology , Neoplasms/therapy , Quality of Life/psychology , Social Support , Surveys and Questionnaires , Survivorship , Young AdultABSTRACT
BACKGROUND: COVID-19 is associated with increased morbidity and mortality in patients with chronic kidney disease (CKD) stages G4-G5, on dialysis or after kidney transplantation (kidney replacement therapy, KRT). SARS-CoV-2 vaccine trials do not elucidate if SARS-CoV-2 vaccination is effective in these patients. Vaccination against other viruses is known to be less effective in kidney patients. Our objective is to assess the efficacy and safety of various types of SARS-CoV-2 vaccinations in patients with CKD stages G4-G5 or on KRT. METHODS: In this national prospective observational cohort study we will follow patients with CKD stages G4-G5 or on KRT (n = 12,000) after SARS-CoV-2 vaccination according to the Dutch vaccination program. Blood will be drawn for antibody response measurements at day 28 and month 6 after completion of vaccination. Patient characteristics and outcomes will be extracted from registration data and questionnaires during 2 years of follow-up. Results will be compared with a control group of non-vaccinated patients. The level of antibody response to vaccination will be assessed in subgroups to predict protection against COVID-19 breakthrough infection. RESULTS: The primary endpoint is efficacy of SARS-CoV-2 vaccination determined as the incidence of COVID-19 after vaccination. Secondary endpoints are the antibody based immune response at 28 days after vaccination, the durability of this response at 6 months after vaccination, mortality and (serious) adverse events. CONCLUSION: This study will fulfil the lack of knowledge on efficacy and safety of SARS-CoV-2 vaccination in patients with CKD stages G4-G5 or on KRT. TRIAL REGISTRATION: The study protocol has been registered in clinicaltrials.gov ( NCT04841785 ). Current knowledge about this subject COVID-19 has devastating impact on patients with CKD stages G4-G5, on dialysis or after kidney transplantation. Effective SARS-CoV-2 vaccination is very important in these vulnerable patient groups. Recent studies on vaccination in these patient groups are small short-term studies with surrogate endpoints. Contribution of this study Assessment of incidence and course of COVID-19 after various types of SARS-CoV-2 vaccination during a two-year follow-up period in not only patients on dialysis or kidney transplant recipients, but also in patients with CKD stages G4-G5. Quantitative analysis of antibody response after SARS-CoV-2 vaccination and its relationship with incidence and course of COVID-19 in patients with CKD stages G4-G5, on dialysis or after kidney transplantation compared with a control group. Monitoring of (serious) adverse events and development of anti-HLA antibodies. Impact on practice or policy Publication of the study design contributes to harmonization of SARS-CoV-2 vaccine study methodology in kidney patients at high-risk for severe COVID-19. Data on efficacy of SARS-CoV-2 vaccination in patients with CKD will provide guidance for future vaccination policy.
Subject(s)
COVID-19 Vaccines , Kidney Transplantation , Renal Dialysis , Renal Insufficiency, Chronic/therapy , COVID-19 Vaccines/administration & dosage , Cohort Studies , Humans , Netherlands , Observational Studies as Topic , Prospective Studies , Time FactorsABSTRACT
The objective of this study was to characterize the association between body condition score (BCS) and BCS change (ΔBCS), determined by an automated camera system at multiple time points, and the subsequent pregnancy per first artificial insemination (P/AI1) of Holstein cows. A retrospective observational study was completed using data collected from 11,393 lactations in 7,928 Holstein cows calving between April 2019 and March 2021 in a commercial dairy operation located in Colorado. Cows were classified as primiparous or multiparous. Scores generated by BCS cameras at dry-off, calving, 21 days in milk (DIM), 56 DIM, and first artificial insemination were selected for the analyses and subsequently categorized as low (≤lower quartile), moderate (interquartile range), and high (≥upper quartile). Changes in BCS were calculated by periods of interest as change from dry-off to calving (multiparous cows); change from calving to 21 DIM; change from calving to 56 DIM; and change from calving to first artificial insemination and assigned into categories as large loss of BCS (top 25% of cows losing BCS); moderate loss (bottom 75% of cows losing BCS); no change (ΔBCS = 0); or gain of BCS (ΔBCS > 0). Data were examined in primiparous and multiparous cows separately using logistic regression and time-to-event analyses. Initial univariable models were followed by multivariable models that considered calving season, occurrence of disease, and milk yield up to 60 DIM as covariables. The logistic regression analyses indicated that in both parity groups the associations between BCS category and P/AI1 were more evident at 21 DIM, 56 DIM, and first artificial insemination, with lower odds of P/AI1 in cows in the low BCS category. Likewise, cows with large loss in BCS between calving and 21 DIM, calving and 56 DIM, and calving and first artificial insemination had lower odds of P/AI1 compared with other categories of ΔBCS within the same period of interest. Similarly, survival analyses evidenced that cows in the low BCS category required more time to get pregnant. In agreement, differences in the dynamics of the average daily BCS during the first 90 DIM were evident when cows were grouped by first AI outcome (pregnant vs. nonpregnant) and by their time to pregnancy category (<90 DIM; 91-150 DIM; or >150 DIM), with cows with reduced fertility showing lower BCS up to 90 DIM. Overall, low BCS and more pronounced reductions in BCS occurring closer to first artificial insemination resulted in lower odds of pregnancy per artificial insemination.
Subject(s)
Insemination, Artificial , Lactation , Animals , Cattle , Female , Fertility , Insemination, Artificial/veterinary , Milk , Parity , PregnancyABSTRACT
Heat stress has negative consequences for milk production and reproduction of dairy cattle. These adverse effects are likely to increase because of climate change and anticipated increases in milk yield. Some of the variation among cows in ability to resist effects of heat stress is genetic. The current objective of this observational study was to assess the effectiveness of the Australian breeding value for heat tolerance (ABVHT) based on the decline in milk yield with heat stress for predicting cow differences in effects of heat stress on regulation of body temperature, milk production, and reproductive function. Genomic breeding values for heat tolerance were calculated for 12,487 cows from a single California dairy farm. Rectal temperature in the afternoon (1100-2045 h) was measured on a subset of 626 lactating cows with ABVHT ≥102 (heat tolerant) or <102 (heat sensitive). Rectal temperature was 0.12°C lower for heat-tolerant cows than heat-sensitive cows. Vaginal temperatures were measured every 15 min for 5 d in 118 cows with ABVHT ≥108 (extreme heat tolerant) or <97 (extreme heat sensitive). Vaginal temperature was 0.07°C lower for extreme heat-tolerant cows than extreme heat-sensitive cows. Lactation records for 4,703 cows with ABVHT were used to evaluate seasonal variation in first 90-d milk yield, fat percent, and protein percent for each ABVHT quartile. Overall, cows with higher ABVHT had lower milk yield, fat percentage, and protein percentage and higher first service pregnancy rate. There was no summer depression in production or reproduction or interactions between season and ABVHT quartile. We observed that ABVHT can successfully identify heat-tolerant cows that maintain lower body temperatures during heat stress. The lack of a pronounced seasonality in milk production or reproduction precluded evaluation of whether ABVHT is related to the magnitude of effect of heat stress on those traits.
Subject(s)
Heat Stress Disorders , Thermotolerance , Animals , Australia , Cattle , Female , Heat Stress Disorders/metabolism , Heat Stress Disorders/veterinary , Heat-Shock Response , Hot Temperature , Lactation , Milk/metabolism , PregnancyABSTRACT
Clinical mastitis (CM) incidence is considerable in terms of cows affected per year, but cases are much less common in terms of detections per cow per milking. From a modeling perspective, where predictions are made every time any cow is milked, low CM incidence per cow day makes training, evaluating, and applying CM prediction models a challenge. The objective of this study was to build models for predicting CM incidence using time-series sensor data and choose models that maximize net return based on a cost matrix. Data collected from 2 university dairy farms, the University of Florida and Virginia Polytechnic Institute and State University, were used to gather representative data, including 110,156 milkings and 333 CM cases. Variables used in the models were milk yield, protein, lactose, fat, electrical conductivity, days in milk, lactation number, and activity as the number of steps, lying time, lying bouts, and lying bout duration. Models that predicted either likelihood of CM caused by gram-negative (GN) or gram-positive (GP) bacteria on each day were derived using extreme gradient boosting with weighting favoring true-positive cases, logistic responses, and log-loss errors. Model accuracies were determined using data randomly held out from the training set on each run. All variables considered were in terms of change (slope) over previous days, including the day CM was visually detected. The GN models had a median sensitivity (Se) of 52.6% and specificity (Sp) of 99.8%, whereas the GP models had a median Se of 37.5% and Sp of 99.9% when tested on the held-out data. In our models optimized to reduce cost from predictions, the Se was much less than Sp, suggesting that CM models might benefit from greater model weighting placed on Sp. Results also highlight the importance of positive predictive value (true positive cases per predicted positive case) along with Sp and Se, as models built on sparse data tend to predict too many false-positive cases. The calculated partial net return of our GN and GP models were -$0.15 and -$0.10 per cow per lactation, respectively, whereas International Organization for Standardization (ISO) standard models with Se of 80% and Sp of 99% would return -$1.32 per cow per lactation. Models chosen that minimized the cost to the farmer differed markedly from models that met ISO guidelines, showing asymmetry in targets between Sp and Se when the disease incidence rate is low. Because of the unique challenges that low-incidence diseases like CM present, we recommend that future CM predictive models consider the economic and practical implications in addition to the traditional model evaluation metrics.
Subject(s)
Dairying , Mastitis, Bovine , Animals , Cattle , Dairying/methods , Farms , Female , Incidence , Lactation , Mastitis, Bovine/microbiology , Milk/metabolismABSTRACT
PURPOSE: The aim of this study was to investigate whether computer-assisted cryotherapy is effective in reducing postoperative pain and analgesics consumption, next to improving functional outcome and patient satisfaction after total knee arthroplasty (TKA). The hypothesis is that computer-assisted cryotherapy has positive effects on postoperative pain after TKA. METHODS: A single-centre non-blinded randomised controlled trial was designed to study the early (first postoperative week) and late (2 and 6 weeks postoperatively) additive effect of computer-assisted cooling after TKA. Participants scheduled for a TKA were randomly allocated to a cold (cryotherapy) C-group or a regular (control) R-group. Next to usual postoperative care for both groups, the C-group received computer-assisted cryotherapy during the first seven postoperative days. Primary outcome was pain, monitored with the numerical rating scale for pain and use of opioid escape medication. Secondary outcomes were function and swelling, monitored by active range of motion, timed up and go test and circumference measurements; patient-reported outcome measurements (KOOS and WORQ questionnaires); and patient satisfaction, monitored by the numerical rating scale for satisfaction. RESULTS: 102 patients participated in this study, both groups contained 51 patients. On most days during the first week, patients in the C-group scored significantly lower NRS pain scores and registered significantly less use of opioid escape medication. In a sub-analysis of 57 patients using the same standard pain protocol, patients in the C-group (n = 28) used less oxycodone during the first postoperative week. There were no significant differences between both groups in active range of motion, timed up and go, or circumference measurements. For the WORQ questionnaire, there was a significant difference between the two groups 6 weeks postoperatively in favour of the C-group. This could be however due to a reduced validity of this questionnaire shortly after TKA. The satisfaction score was not significantly different between both groups. CONCLUSION: Computer-assisted cryotherapy following TKA can be beneficial during the first postoperative week in terms of pain reduction and diminished opioid consumption. No clear differences in knee function or swelling were seen. LEVEL OF EVIDENCE: Therapeutic study with level of evidence I.
Subject(s)
Arthroplasty, Replacement, Knee , Analgesics, Opioid/therapeutic use , Arthroplasty, Replacement, Knee/adverse effects , Arthroplasty, Replacement, Knee/methods , Computers , Cryotherapy , Edema/etiology , Humans , Pain, Postoperative/etiology , Postural Balance , Range of Motion, Articular , Time and Motion Studies , Treatment OutcomeABSTRACT
In this review we address the human in human robot collaboration (HRC). Although there are different hypotheses on potential effects of HRC on job quality, defined as the quality of the working environment and its effect on the employee's well-being, a comprehensive theory is still lacking. How does HRC influence job quality on an individual level and how can we adapt HRC to boost positivity at work? We identified four job quality related factors that are of relevance in HRC: (1) Cognitive Workload, (2) Collaboration Fluency, (3) Trust, and (4) Acceptance and Satisfaction. Increasing awareness and being able to adapt the robot to the individual operator are crucial to improve the aforementioned factors. Implementing predictable robots, that offer a clear advantage to the human and take into account operators' preferences, will bring us closer to a human-centered collaboration. Practitioner Summary: The effect of human robot collaboration (HRC) on job quality is still under debate. Design characteristics of HRC, such as collaboration design, robot design, and workplace design affect job quality related factors. Using a participatory design approach, as to align robot capabilities to end-users' preferences, will enhance HRC and improve job quality. Abbreviations: HRC: human robot collaboration; OECD: organisation for economic co-operation and development.
Subject(s)
Robotics , Humans , WorkplaceABSTRACT
Background The societal discourse concerning gender(diversity) is changing rapidly and this trickles down to our consultation rooms. Most requests for gender-affirming medical care (GAMC) are well-considered and evidently necessary. In more complex presentations, however, challenges may arise. Aim To provide insight into clinical challenges in decision-making regarding GAMC. Method Discussing relevant literature by means of a clinical vignette. Results Dilemmas may arise in assessing competence to give consent to treatment. In differential diagnosis, it may be challenging to discern the interaction between gender incongruence and co-occurring mental conditions. Conclusion It is unethical to prima facie deny access to GAMC to those presenting with co-occurring mental health concerns and/or challenges in decision-making capacity. For this population, specialist care and comprehensive deliberation are indicated. To arrive at good care and decision-making, sufficient knowledge and sensitivity among, and cooperation with other mental health services is indispensable.
Subject(s)
Mental Health Services , Patient Care , Humans , Mental Health , Referral and ConsultationABSTRACT
PURPOSE: This study aimed to increase our understanding of the psychosocial well-being of young adult childhood cancer survivors (YACCS) as well as the positive and negative impacts of cancer. METHODS: YACCS (aged 18-30, diagnosed ≤ 18, time since diagnosis ≥ 5 years) cross-sectionally filled out the "Pediatric Quality of Life Inventory Young Adults" (PedsQL-YA), "Hospital Anxiety and Depression Scale" (HADS), and "Checklist Individual Strengths" (CIS-20R) to measure fatigue and survivor-specific "Impact of Cancer - Childhood Survivors" (IOC-CS), which measures the long-term impact of childhood cancer in several domains. Descriptive statistics (IOC-CS), logistic regression (HADS, CIS-20R), and ANOVA (PedsQL-YA, HADS, CIS-20R) were performed. Associations between positive and negative impacts of childhood cancer and psychosocial outcomes were examined with linear regression analyses. RESULTS: YACCS (N = 151, 61.6% female, mean age 24.1 ± 3.6, mean time since diagnosis 13.6 ± 3.8) reported lower HRQOL (- .4 ≤ d ≤ - .5, p ≤ .001) and more anxiety (d = .4, p ≤ .001), depression (d = .4, p ≤ .01), and fatigue (.3 ≤ d ≤ .5, p ≤ .001) than young adults from the general Dutch population. They were at an increased risk of experiencing (sub)clinical anxiety (OR = 1.8, p = .017). YACCS reported more impact on scales representing a positive rather than negative impact of CC. Various domains of impact of childhood cancer were related to psychosocial outcomes, especially "Life Challenges" (HRQOL ß = - .18, anxiety ß = .36, depression ß = .29) and "Body & Health" (HRQOL ß = .27, anxiety ß = - .25, depression ß = - .26, fatigue ß = - .47). CONCLUSION: YACCS are vulnerable to psychosocial difficulties, but they also experience positive long-term impacts of childhood cancer. Positive and negative impacts of childhood cancer were associated with psychosocial outcomes in YACCS. Screening of psychosocial outcomes and offering targeted interventions are necessary to optimize psychosocial long-term follow-up care for YACCS.
Subject(s)
Cancer Survivors/psychology , Neoplasms/psychology , Quality of Life/psychology , Vulnerable Populations/psychology , Adolescent , Adult , Female , Humans , Male , Young AdultABSTRACT
BACKGROUND: In 2019, more than 30 % of all newly transplanted kidney transplant recipients in The Netherlands were above 65 years of age. Elderly patients are less prone to rejection, and death censored graft loss is less frequent compared to younger recipients. Elderly recipients do have increased rates of malignancy and infection-related mortality. Poor kidney transplant function in elderly recipients may be related to both pre-existing (i.e. donor-derived) kidney damage and increased susceptibility to nephrotoxicity of calcineurin inhibitors (CNIs) in kidneys from older donors. Hence, it is pivotal to shift the focus from prevention of rejection to preservation of graft function and prevention of over-immunosuppression in the elderly. The OPTIMIZE study will test the hypothesis that reduced CNI exposure in combination with everolimus will lead to better kidney transplant function, a reduced incidence of complications and improved health-related quality of life for kidney transplant recipients aged 65 years and older, compared to standard immunosuppression. METHODS: This open label, randomized, multicenter clinical trial will include 374 elderly kidney transplant recipients (≥ 65 years) and consists of two strata. Stratum A includes elderly recipients of a kidney from an elderly deceased donor and stratum B includes elderly recipients of a kidney from a living donor or from a deceased donor < 65 years. In each stratum, subjects will be randomized to a standard, tacrolimus-based immunosuppressive regimen with mycophenolate mofetil and glucocorticoids or an adapted immunosuppressive regimen with reduced CNI exposure in combination with everolimus and glucocorticoids. The primary endpoint is 'successful transplantation', defined as survival with a functioning graft and an eGFR ≥ 30 ml/min per 1.73 m2 in stratum A and ≥ 45 ml/min per 1.73 m2 in stratum B, after 2 years, respectively. CONCLUSIONS: The OPTIMIZE study will help to determine the optimal immunosuppressive regimen after kidney transplantation for elderly patients and the cost-effectiveness of this regimen. It will also provide deeper insight into immunosenescence and both subjective and objective outcomes after kidney transplantation in elderly recipients. TRIAL REGISTRATION: ClinicalTrials.gov: NCT03797196 , registered January 9th, 2019. EudraCT: 2018-003194-10, registered March 19th, 2019.
Subject(s)
Calcineurin Inhibitors/administration & dosage , Everolimus/administration & dosage , Immunosuppressive Agents/therapeutic use , Kidney Transplantation , Mycophenolic Acid/administration & dosage , Tacrolimus/administration & dosage , Aged , Calcineurin Inhibitors/adverse effects , Drug Therapy, Combination , Everolimus/adverse effects , Humans , Immune System/physiology , Immunosuppression Therapy/methods , Immunosuppressive Agents/adverse effects , Mycophenolic Acid/adverse effects , Tacrolimus/adverse effectsABSTRACT
The objectives of this study were to investigate the association of body weight (BW) at first calving (BWFC) and maturity rate (MR; BWFC as a percentage of mature BW) with first-lactation 305-d milk yield (FLMY), milk yield (MY) in the 24 mo following first calving (24MMY), herd life, and BW change (BWC) through the first month of lactation in Holstein heifers. We retrieved daily milk production records and daily BW records from AfiFarm (S. A. E. Afikim, Kibbutz Afikim, Israel). The data set included daily records for 1,110 Holstein cows from The Pennsylvania State University (n = 435,002 records) and 1,229 Holstein cows from University of Florida (n = 462,013 records) that calved from 2001 to 2016. Body weight at first calving was defined as mean BW from 5 to 10 d in milk of the first lactation, whereas BWC represented change from BWFC to average BW from 30 to 40 d in milk. First-lactation 305-d MY and 24MMY were analyzed with a linear model that included effects of farm-year-season of calving, age at calving, and quintiles of BWFC, MR, or BWC. Body weight change was analyzed with the same model to determine associations with BWFC. Survival analysis was performed to estimate the effect of BWFC on survival. Heifers in the top 60% of BWFC had significantly higher FLMY (10,041 to 10,084 kg) than lighter heifers (9,683 to 9,917 kg), but there was wide variation in every quintile, and no relationship of BWFC and FLMY existed within the top 60%. Relationships between BWFC and 24MMY were not significant. Heifers with higher BWFC or MR lost significantly more BW in early lactation. Although BWFC and MR were significant predictors of FLMY, they accounted for <3% of variation in FLMY or 24MMY, suggesting that BWFC and MR are not primary contributors to variation in MY. Compared with the lightest heifers, the heaviest heifers were 49% more likely to be culled at a given time. These data indicated that, among heifers managed similarly, heavier heifers produced more milk in first lactation than lighter heifers but lost more BW, faced a higher risk of being culled, and did not produce more milk in the long term. Based on our data, heifers that reach between 73 and 77% MR at first calving can produce more milk in their first lactation without sacrificing long-term MY and herd life.
Subject(s)
Body Weight/physiology , Cattle/physiology , Milk , Animals , Colostrum , Female , Group Processes , Lactation , Parity , Pregnancy , SeasonsABSTRACT
The association between dry period length (DPL) and time to culling and pregnancy in the subsequent lactation may be important for the economically optimal length of the dry period. Therefore, this study aimed to (1) quantify the association between DPL and hazard of culling and pregnancy in the subsequent lactation; (2) develop continuous functions of DPL for the hazard ratios of culling and pregnancy; and (3) investigate the effect of a cause-specific hazards model and a subdistribution model to analyze competing events. The data used in this observational cohort study were from dairy herd improvement milk test lactation records from 40 states in the United States. After edits, there remained 1,108,515 records from 6,730 herds with the last days dry in 2014 or 2015. The records from 2 adjacent lactations (current, subsequent) were concatenated with the DPL of interest, 21 to 100 d, in between both lactations. We defined 8 DPL categories of 10 d each. Kaplan-Meier survival curves were used to show associations between DPL and time to culling or pregnancy for 3 lactation groups: lactation 1 and 2, lactation 2 and 3, and lactation 3 and greater. To control for confounding factors in Cox proportional models, we included 6 current lactation covariates and 3 time-dependent variables in the survival models. Hazard ratios of culling were estimated for 4 days in milk (DIM) categories from 1 to 450 DIM. Hazard ratios of pregnancy were estimated for 3 DIM categories from 61 to 300 DIM. Competing risk analysis of 8 disposal codes (i.e., farmer reported reasons) for culling and the culling event for pregnancy were conducted by a cause-specific hazards model and a subdistribution model. Hazard ratios were also estimated as quadratic polynomials of DPL. Compared with the reference DPL category of 51 to 60 d, hazard ratios of culling and pregnancy of the other 7 DPL categories ranged between 0.70 and 1.49, and 0.93 and 1.15, respectively. Short DPL were associated with lower risk of culling in the early lactation but not over the entire lactation. Short DPL were associated with greater hazard of pregnancy. Trends in hazard ratios over the ranges of the 8 DPL categories were not always consistent. Competing risk analysis with both models provided little differences in hazard ratios of culling and pregnancy. In conclusion, variations in DPL were associated with meaningful differences in the hazard ratios for culling and pregnancy and minor differences in the relative frequency of disposal codes. Subdistribution hazards models produced hazard ratios similar to cause-specific hazard models. The quadratic polynomials may be useful for decision support on customization of DPL for individual cows.
Subject(s)
Dairying , Lactation , Animals , Cattle , Female , Milk , Pregnancy , Proportional Hazards Models , TimeABSTRACT
Sensor technologies for mastitis detection have resulted in the collection and availability of a large amount of data. As a result, scientific publications reporting mastitis detection research have become less driven by approaches based on biological assumptions and more by data-driven modeling. Most of these approaches try to predict mastitis events from (combinations of) raw sensor data to which a wide variety of methods are applied originating from machine learning and classical statistical approaches. However, an even wider variety in terminologies is used by researchers for methods that are similar in nature. This makes it difficult for readers from other disciplines to understand the specific methods that are used and how these differ from each other. The aim of this paper was to provide a framework (filtering, transformation, and classification) for describing the different methods applied in sensor data-based clinical mastitis detection research and use this framework to review and categorize the approaches and underlying methods described in the scientific literature on mastitis detection. We identified 40 scientific publications between 1992 and 2020 that applied methods to detect clinical mastitis from sensor data. Based on these publications, we developed and used the framework and categorized these scientific publications into the 2 data processing techniques of filtering and transformation. These data processing techniques make raw data more amendable to be used for the third step in our framework, that of classification, which is used to distinguish between healthy and nonhealthy (mastitis) cows. Most publications (n = 34) used filtering or transformation, or a combination of these 2, for data processing before classification, whereas the remaining publications (n = 6) classified the observations directly from raw data. Concerning classification, applying a simple threshold was the most used method (n = 19 publications). Our work identified that within approaches several different methods and terminologies for similar methods were used. Not all publications provided a clear description of the method used, and therefore it seemed that different methods were used between publications, whereas in fact just a different terminology was used, or the other way around. This paper is intended to serve as a reference for people from various research disciplines who need to collaborate and communicate efficiently about the topic of sensor-based mastitis detection and the methods used in this context. The framework used in this paper can support future research to correctly classify approaches and methods, which can improve the understanding of scientific publication. We encourage future research on sensor-based animal disease detection, including that of mastitis detection, to use a more coherent terminology for methods, and clearly state which technique (e.g., filtering) and approach (e.g., moving average) are used. This paper, therefore, can serve as a starting point and further stimulates the interdisciplinary cooperation in sensor-based mastitis research.
Subject(s)
Cattle Diseases , Mastitis , Animals , Cattle , Female , Language , Machine Learning , Mastitis/veterinaryABSTRACT
Our objective was to develop predictive models of 305-d mature-equivalent milk, fat, and protein yields in the subsequent lactation as continuous functions of the number of days dry (DD) in the current lactation. In this retrospective cohort study with field data, we obtained DHIA milk recording lactation records with the last DD in 2014 or 2015. Cows included had DD from 21 to 100 d. After editing, 1,030,141 records from cows in 7,044 herds remained. Three parity groups of adjacent (current, subsequent) lactations were constructed. We conducted all analyses by parity group and yield component. We first applied control models to pre-adjust the yields in the subsequent lactation for potentially confounding effects. Control models included the covariates mature-equivalent yield, days open, somatic cell score at 180 d pregnant, daily yield at 180 d pregnant, and a herd-season random effect, all observed in the current lactation. Days dry was not included. Second, we modeled residuals from control models with smooth piecewise regression models consisting of a simple linear, quadratic, and another simple linear equation depending on DD. Yield deviations were calculated as differences from predicted mature-equivalent yield at 50 DD. For validation, predictions of yield deviations from piecewise models by DD were compared with predictions from local regression for the DHIA field records and yield deviations reported in 38 experimental and field studies found in the literature. Control models reduced the average root mean squared prediction error by approximately 21%. Yield deviations were increasingly more negative for DD shorter than 50 d, indicating lower yields in the subsequent lactation. For short DD, the decrease in 305-d mature-equivalent milk yield ranged from 43 to 53 kg per DD. For mature-equivalent fat and protein yields, decreases were between 1.28 and 1.71 kg per DD, and 1.06 and 1.50 kg per DD, respectively. Yield deviations often were marginally positive and increasing for DD >50, so that the highest yield in the subsequent lactation was predicted for 100 DD. For long DD, the 305-d mature-equivalent milk yield increased at most 4.18 kg per DD. Patterns in deviations for fat and protein yield were similar to those for milk yield deviations. Predictions from piecewise models and local regressions were very similar, which supports the chosen functional form of the piecewise models. Yield deviations from field studies in the literature typically were decreasing when DD were longer, likely because of insufficient control for confounding effects. In conclusion, piecewise models of mature-equivalent milk, fat, and protein yield deviations as continuous functions of DD fit the observed data well and may be useful for decision support on the optimal dry period length for individual cows.
Subject(s)
Cattle/physiology , Dairying , Milk , Animals , Cohort Studies , Female , Glycolipids/metabolism , Glycoproteins/metabolism , Lactation , Lipid Droplets/metabolism , Milk/chemistry , Milk/metabolism , Milk Proteins/metabolism , Models, Biological , Parity , Pregnancy , Retrospective Studies , Time FactorsABSTRACT
The objective of this study was to estimate the cost of metritis in dairy herds. Data from 11,733 dairy cows from 16 different farms located in 4 different regions of the United States were compiled for up to 305 d in milk, and 11,581 cows (2,907 with and 8,674 without metritis) were used for this study. Metritis was defined as fetid, watery, red-brownish vaginal discharge that occurs ≤21 d in milk. Continuous outcomes such as 305-d milk production, milk sales ($/cow), cow sales ($/cow), metritis treatment costs ($/cow), replacement costs ($/cow), reproduction costs ($/cow), feeding costs ($/cow), and gross profit per cow ($/cow) were analyzed using mixed effect models using the MIXED procedure of SAS (SAS Institute Inc., Cary, NC). Gross profit was also compared using the Kruskal-Wallis test. Dichotomous outcomes such as pregnant and culling by 305 d in milk were analyzed using the GLIMMIX procedure of SAS. Time to pregnancy and culling were analyzed using the PHREG procedure of SAS. Models included the fixed effects of metritis, parity, and the interaction between metritis and parity, and farm as the random effect. Variables were considered significant when P ≤ 0.05. Metritis cost was calculated by subtracting the gross profit of cows with metritis from the gross profit of cows without metritis. A stochastic analysis was performed with 10,000 iterations using the observed results from each group. Milk yield and proportion of cows pregnant were lesser for cows with metritis than for cows without metritis, whereas the proportion of cows leaving the herd was greater for cows with metritis than for cows without metritis. Milk sales, feeding costs, residual cow value, and gross profit were lesser for cows with metritis than for cows without metritis. Cow sales and replacement costs were greater for cows with metritis than for cows without metritis. The mean cost of metritis from the study herds was $511 and the median was $398. The stochastic analysis showed that the mean cost of a case of metritis was $513, with 95% of the scenarios ranging from $240 to $884, and that milk price, treatment cost, replacement cost, and feed cost explained 59%, 19%, 12%, and 7%, respectively, of the total variation in cash flow differences. In conclusion, metritis caused large economic losses to dairy herds by decreasing milk production, reproduction, and survival in the herd.